Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Crypto currencies is Beyond Innovation|Michael Wu,Founder and CEO,Amber Group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Michael Wu is the Co-Founder and CEO of Amber Group.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Is Hiring a Financial Planner Worth It? Exploring the Value
00:10:00
Pioneering High-Grade Iron Ore for the Green Steel Revolution | David Cataford, CEO , Champion Iron Ltd.
00:10:00
Unlocking growth and quality in the Nordic real estate market through strategic urban retail specialization | Marcel Kokkeel, CEO, Citycon Oyj.
00:10:00
Transforming Plastic Waste into Sustainable Feedstocks and Fuels: Agilyx's Latest Partnerships Propel Circular Economy Solutions | Tim Stedman , CEO, Agilyx AS.
00:10:00
Andrew Bogart: Millennium's Portfolio Manager on His Commitment to Community Service and Mentorship with Bigs & Littles NYC
00:10:00
Conversations with Clinton and Bush: Leadership Reflections
00:10:00
A Great Investor Adopts a More Conservative Strategy While Maintaining a Consistent Stock-Picking Approach
00:10:00
Paul West-Sells on Western Copper and Gold's Casino Project Development in Yukon
00:10:00
Full-Year Results Highlight Strong Financial Performance and Growth Strategy for Wind Farm Operator | Stephen Lilley, Fund manager, Greencoat UK Wind PLC.
00:10:00
Intellectual Property Battles: Anglo-American Power Shift in Defense Technology|Katherine C. Epstein
00:10:00
Justice Resources: High-Grade Gold Discovery in Senegal's Orogenic Gold Belt
00:10:00
CEO Perspectives: Navigating Fiscal Policy, Market Volatility, and Economic Growth | John Koudounis, CEO , Calamos Investments LLC.